5SYE image
Deposition Date 2016-08-10
Release Date 2017-02-01
Last Version Date 2024-03-06
Entry Detail
PDB ID:
5SYE
Title:
Near-atomic resolution cryo-EM reconstruction of doubly bound Taxol- and peloruside-stabilized microtubule
Biological Source:
Source Organism:
Sus scrofa (Taxon ID: 9823)
Method Details:
Experimental Method:
Resolution:
3.50 Å
Aggregation State:
HELICAL ARRAY
Reconstruction Method:
HELICAL
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Tubulin alpha chain
Chain IDs:A
Chain Length:437
Number of Molecules:1
Biological Source:Sus scrofa
Polymer Type:polypeptide(L)
Molecule:Tubulin beta chain
Chain IDs:B
Chain Length:426
Number of Molecules:1
Biological Source:Sus scrofa
Primary Citation
Insights into the Distinct Mechanisms of Action of Taxane and Non-Taxane Microtubule Stabilizers from Cryo-EM Structures.
J. Mol. Biol. 429 633 646 (2017)
PMID: 28104363 DOI: 10.1016/j.jmb.2017.01.001

Abstact

A number of microtubule (MT)-stabilizing agents (MSAs) have demonstrated or predicted potential as anticancer agents, but a detailed structural basis for their mechanism of action is still lacking. We have obtained high-resolution (3.9-4.2Å) cryo-electron microscopy (cryo-EM) reconstructions of MTs stabilized by the taxane-site binders Taxol and zampanolide, and by peloruside, which targets a distinct, non-taxoid pocket on β-tubulin. We find that each molecule has unique distinct structural effects on the MT lattice structure. Peloruside acts primarily at lateral contacts and has an effect on the "seam" of heterologous interactions, enforcing a conformation more similar to that of homologous (i.e., non-seam) contacts by which it regularizes the MT lattice. In contrast, binding of either Taxol or zampanolide induces MT heterogeneity. In doubly bound MTs, peloruside overrides the heterogeneity induced by Taxol binding. Our structural analysis illustrates distinct mechanisms of these drugs for stabilizing the MT lattice and is of relevance to the possible use of combinations of MSAs to regulate MT activity and improve therapeutic potential.

Legend

Protein

Chemical

Disease

Primary Citation of related structures